BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 18645269)

  • 1. Contribution of Cyclin-dependent Kinase Inhibitor 1B Genotypes to Childhood Leukemia Risk.
    Pei JS; Chang WS; Hsu PC; Chen CC; Yang YC; Hsu SW; Hsu YN; Wang YC; Wang CH; Tsai CW; Bau DT
    In Vivo; 2022; 36(4):1637-1642. PubMed ID: 35738638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Genetic Variations in
    Híveš M; Jurečeková J; Kliment J; Grendár M; Kaplán P; Dušenka R; Evin D; Vilčková M; Holečková KH; Sivoňová MK
    Cancer Genomics Proteomics; 2022; 19(3):362-371. PubMed ID: 35430569
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Zhang M; Liang Q; Zhang L; Hao Z; Zhou J; Zhang L; Fan S; Liang C
    Dis Markers; 2018; 2018():1418609. PubMed ID: 29750086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Association Between CDKN1B rs2066827 Polymorphism and Susceptibility to Cancer.
    Lu Y; Gao K; Zhang M; Zhou A; Zhou X; Guan Z; Shi X; Ge S
    Medicine (Baltimore); 2015 Nov; 94(46):e1217. PubMed ID: 26579796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.
    Circelli L; Ramundo V; Marotta V; Sciammarella C; Marciello F; Del Prete M; Sabatino L; Pasquali D; Izzo F; Scala S; Colao A; Faggiano A; Colantuoni V;
    J Cell Mol Med; 2015 Jul; 19(7):1735-41. PubMed ID: 25824098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p27(Kip1) V109G polymorphism and cancer risk: a systematic review and meta-analysis.
    Wei F; Xu J; Tang L; Shao J; Wang Y; Chen L; Guan X
    Cancer Biother Radiopharm; 2012 Dec; 27(10):665-71. PubMed ID: 22823061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The AR dependent cell cycle: mechanisms and cancer relevance.
    Schiewer MJ; Augello MA; Knudsen KE
    Mol Cell Endocrinol; 2012 Apr; 352(1-2):34-45. PubMed ID: 21782001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis.
    Shaik AP; Jamil K; Das P
    Urol J; 2009; 6(2):78-86. PubMed ID: 19472123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular methods for predicting the metastatic potential of prostate cancer.
    Schalken JA
    Cancer Surv; 1991; 11():43-54. PubMed ID: 1726788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDKN1B V109G polymorphism frequency and prostate cancer risk in Taiwan.
    Huang SP; Yu CC; Liu CC; Wu TT; Huang CH; Wu MT
    Urol Int; 2008; 81(1):36-40. PubMed ID: 18645269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.
    Naidu R; Har YC; Taib NA
    J Exp Clin Cancer Res; 2007 Mar; 26(1):133-40. PubMed ID: 17550142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCND1 and CDKN1B polymorphisms and risk of breast cancer.
    Canbay E; Eraltan IY; Cercel A; Isbir T; Gazioglu E; Aydogan F; Cacina C; Cengiz A; Ferahman M; Zengin E; Unal H
    Anticancer Res; 2010 Jul; 30(7):3093-8. PubMed ID: 20683061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the V109G polymorphism of the p27 gene and the risk and progression of oral squamous cell carcinoma.
    Li G; Sturgis EM; Wang LE; Chamberlain RM; Spitz MR; El-Naggar AK; Hong WK; Wei Q
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3996-4002. PubMed ID: 15217930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer.
    Fukuda H; Tsuchiya N; Narita S; Kumazawa T; Horikawa Y; Inoue T; Saito M; Yuasa T; Matsuura S; Satoh S; Ogawa O; Habuchi T
    Oncol Rep; 2007 Nov; 18(5):1155-63. PubMed ID: 17914566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer.
    Wang L; Habuchi T; Tsuchiya N; Mitsumori K; Ohyama C; Sato K; Kinoshita H; Kamoto T; Nakamura A; Ogawa O; Kato T
    Cancer Res; 2003 Aug; 63(15):4407-11. PubMed ID: 12907612
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.